TABLE 2.
Pneumococcal strains used in this study
| Strain | Descriptiona | Reference or source |
|---|---|---|
| TIGR4 | Invasive clinical isolate, capsular serotype 4, sensitive to antibiotics | 85 |
| D39 | Avery strain, clinical isolate, capsular serotype 2; sensitive to antibiotics | 87 |
| R6 | D39-derivative unencapsulated laboratory strain, sensitive to antibiotics | 87 |
| R6ΔspxBΔlctO | R6-derivative, hydrogen peroxide and autolysis deficient strain. | 88 |
| R6ΔlytAΔlytC | R6-derivative, autolysis deficient strain | 89 |
| EF3030 | Clinical isolate, capsular serotype 19F, sensitive to antibiotics | 50, 90 |
| S. pneumoniae ATCC 49619 | Invasive reference strain, recommended by the CLSIb for antimicrobial-sensitive test serotype 19F | American Type Culture Collection, 43 |
| GA44288 | Clinical isolate, capsular serotype 19A; ERY, TET, AMX, CXM, CLI, SXT, MEM, PEN, CRO, CTX | 91 |
| GA47281 | Clinical isolate, capsular serotype 19F; ERY, TET, AMX, CXM, CLI, SXT, MEM, PEN, CRO, CTX | 91 |
| GA16833 | Clinical isolate, capsular serotype 19F; ERY, TET, CXM | 91 |
| GA17227 | Clinical isolate, capsular serotype 23F; ERY, TET | 91 |
Resistance to amoxicillin (AMX), cefuroxime (CXM), ceftriaxone (CRO), cefotaxime (CTX), clindamycin (CLI), erythromycin (ERY), meropenem (MEM), penicillin (PEN), tetracycline (TET), trimethoprim-sulfamethoxazole (SXT).
CLSI, Clinical and Laboratory Standards Institute.